Optimizing cervical cancer prevention strategies in the United States.

Harrell W. Chesson, Donatus U. Ekwueme, Mona Saraiya, Eileen F. Dunne, Lauri E. Markowitz, The cost-effectiveness of male HPV vaccination in the United States Vaccine. ,vol. 29, pp. 8443- 8450 ,(2011) , 10.1016/J.VACCINE.2011.07.096

Thomas C. Wright, Mark Schiffman, Adding a test for human papillomavirus DNA to cervical-cancer screening. The New England Journal of Medicine. ,vol. 348, pp. 489- 490 ,(2003) , 10.1056/NEJMP020178

Allan Hildesheim, Rolando Herrero, Sholom Wacholder, Ana C Rodriguez, Diane Solomon, M Concepcion Bratti, John T Schiller, Paula Gonzalez, Gary Dubin, Carolina Porras, Silvia E Jimenez, Douglas R Lowy, for the Costa Rican HPV Vaccine Trial Group, None, Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA. ,vol. 298, pp. 743- 753 ,(2007) , 10.1001/JAMA.298.7.743

Cosette M. Wheeler, William C. Hunt, Jack Cuzick, Erika Langsfeld, Amanda Pearse, George D. Montoya, Michael Robertson, Catherine A. Shearman, Philip E. Castle, , A population‐based study of human papillomavirus genotype prevalence in the United States: Baseline measures prior to mass human papillomavirus vaccination International Journal of Cancer. ,vol. 132, pp. 198- 207 ,(2013) , 10.1002/IJC.27608

Anne F. Rositch, Anne E. Burke, Raphael P. Viscidi, Michelle I. Silver, Kathryn Chang, Patti E. Gravitt, Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older women Cancer Research. ,vol. 72, pp. 6183- 6190 ,(2012) , 10.1158/0008-5472.CAN-12-2635

P. E Castle, A. C. Rodriguez, R. D Burk, R. Herrero, S. Wacholder, M. Alfaro, J. Morales, D. Guillen, M. E Sherman, D. Solomon, M. Schiffman, , Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study BMJ. ,vol. 339, ,(2009) , 10.1136/BMJ.B2569

J. J Kim, S. J Goldie, Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States BMJ. ,vol. 339, ,(2009) , 10.1136/BMJ.B3884

S. K. Kjaer, K. Frederiksen, C. Munk, T. Iftner, Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence Journal of the National Cancer Institute. ,vol. 102, pp. 1478- 1488 ,(2010) , 10.1093/JNCI/DJQ356

J. Koshiol, L. Lindsay, J. M. Pimenta, C. Poole, D. Jenkins, J. S. Smith, Persistent Human Papillomavirus Infection and Cervical Neoplasia: A Systematic Review and Meta-Analysis American Journal of Epidemiology. ,vol. 168, pp. 123- 137 ,(2008) , 10.1093/AJE/KWN036

K. Cuschieri, N. Wentzensen, Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia. Cancer Epidemiology, Biomarkers & Prevention. ,vol. 17, pp. 2536- 2545 ,(2008) , 10.1158/1055-9965.EPI-08-0306